Evaluation of IL-6 and IL-17A gene polymorphisms in Iraqi patients infected with COVID-19 and type 2 diabetes mellitus.

doi:10.3233/HAB-230007

Back to search

Article

Evaluation of IL-6 and IL-17A gene polymorphisms in Iraqi patients infected with COVID-19 and type 2 diabetes mellitus.

Human antibodies - 1 Jan 2023

Khalaf Qusay Abdulwahab, Rasool Khetam Habeeb, Naji Eman Natiq

Abstract excerpt

BACKGROUND: In patients with COVID-19, diabetes mellitus type 2 (T2DM) increases the risk of hospitalization and death. Patients who have IL-6 and IL-17A single nucleotide polymorphisms (SNPs) are more likely to have severe COVID-19. This study aims to determine whether SNPs of the IL-6 gene at r...

Topics

Humans
Case-Control Studies
COVID-19
Diabetes Mellitus, Type 2
Gene Frequency
Genetic Predisposition to Disease
Interleukin-17
Interleukin-6
Iraq
Polymorphism, Single Nucleotide

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.